3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Triple Negative Breast Neoplasms
5
Neoplasm Metastasis
3
Urinary Bladder Neoplasms
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Sarcoma
1
Refractory Solid Tumors
1
Liposarcoma
1
HR+HER2- Breast Cancer
1
Carcinoma, Transitional Cell
1
Interventions
trastuzumab deruxtecan
1
sacituzumab govitecan
1
Temozolomide
1
Social Determinants of Health
1
Methylprednisolone
1
Irinotecan
1
Cefixime
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Drug-Related Side Effects and Adverse Reactions
×
eribulin
×
90 days
×
Clear all
No trials found.